Explore NYSORA knowledge base for free:
Explore NYSORA knowledge base for free:
Across NYSORA’s global events one theme consistently emerges: clinicians want to see real innovation. They want to understand not just the science, but the tools and technologies reshaping regional anesthesia, pain management, and perioperative care. That’s why NYSORA continues to support non-CME lunch break presentations for industry partners. These short sessions give companies a high-visibility moment to showcase new technologies, tools, and ideas directly to an audience that’s hungry for practical solutions. This initiative aligns with a long-standing NYSORA vision: to bring clinicians and innovators into the same room, spark meaningful dialogue, and showcase the adoption of safer evidence-based technologies. A Proven Example: Medasense & the NOL Index One of the most impactful industry spotlights at our events has been the presentation by MedaSense Biometrics, the company behind the AI-driven Nociception Level (NOL) Index®. Traditionally, assessing nociception during anesthesia has been subjective and inconsistent. Medasense’s NOL technology introduces a new level of precision. It uses a combination of physiological signals-photoplethysmography (PPG), galvanic skin response, peripheral temperature changes, and motion – to generate a single, personalized NOL value. In practice, this gives clinicians: A clearer, continuous picture of a patient’s nociception level Better insight into block effectiveness A data-driven way to titrate analgesics Reduced risk of both under- and over-treating pain More consistent, predictable outcomes The PMD-200™ monitor, built around the NOL Index, has been recognized as one of the first tools to bring true objectivity into intraoperative nociception monitoring. Its ability to guide analgesia with precision aligns perfectly with the growing focus on individualized anesthesia care, opioid optimization, and safety. At our recent New York event, Pascal Laferriere-Langlois delivered a compelling lunch-time session titled: “Innovation in Regional Anesthesia: Introducing the AI-driven NOL Index for Precision Pain Management.” His session demonstrated exactly what these lunch break presentations are meant to achieve: […]
December 2, 2025
September 7th, 2025 Author: Medasense Biometrics Delivering safe and effective anesthesia requires precise control of hypnosis, analgesia, and, when needed, muscle relaxation. Under general anesthesia, conscious pain is blocked, but the body continues to display unconscious physiologic responses known as nociception. While non-invasive monitors for hypnosis and muscle relaxation are common, there has been no dedicated solution for objective analgesia monitoring. Clinicians have relied on surrogate signs, such as heart rate (HR) and mean arterial pressure (MAP), which are neither sensitive nor specific to nociception. This makes it challenging to evaluate the success of a regional block and to decide whether and when to supplement with additional analgesics. The PMD-200™ Monitor The PMD-200 monitor, powered by the AI-driven NOL-Nociception Level Index® technology, is the first and only FDA-authorized monitor indicated for nociception monitoring in adult patients under general anesthesia in the United States. The system consists of a proprietary monitoring unit with a reusable non-invasive finger probe and a single-use sensor. It captures four physiological signals: Photoplethysmograph (PPG) Galvanic Skin Response (GSR) Peripheral Temperature (Temp) Accelerometer (ACC) Figure 1-PMD-200 Sensing Platform How the NOL Index Works From the PPG and GSR signals, the NOL algorithm extracts and analyzes nociception-related features – including heart rate, heart rate variability, PPG amplitude, and skin conductance level – along with derivatives associated with the autonomic nervous system. Temp and ACC serve as guardrails to ensure signal quality. Figure 2 – PMD-200 Bedside Monitor After a 30-second calibration, the monitor displays a NOL index value (0–100). This value is continuously personalized: initially normalized to large-scale population data, and progressively adapted to the patient’s own physiological responses as more data is gathered. 0 represents no nociceptive response. 100 represents an extreme nociceptive response. Clinical Guidelines Evidence suggests that during general anesthesia: NOL values above 25 for […]
September 25, 2025
NYSORA’s Anesthesia Summit in Leuven brings together a rare mix of clinicians, educators, and industry leaders to exchange knowledge and test solutions in real-world clinical settings. It’s where science, practice, and innovation meet – and where the conversation moves beyond products to the strategies that make anesthesia safer, more efficient, and more effective. For industry partners, NYSORAs’ events offer direct access to anesthesiologists, residents, and hospital decision-makers who are actively seeking solutions to everyday clinical challenges. It’s a setting where feedback is immediate, collaboration is hands-on, and innovation is measured against real clinical needs. One example is B. Braun, whose team joined the June 2025 Anesthesia Summit to engage in discussions on regional anesthesia safety and efficiency. Their participation went beyond product demonstration, practical sessions and exchanges with clinicians on how to improve outcomes through refined techniques and tools. “We see NYSORA Anesthesia Summit as a great opportunity to showcase our market-leading products, connect with our customers, and network. But also to gain valuable insights into the clinical strategies making regional anesthesia safer, more efficient, and even more effective. This is what we at B. Braun are committed to, and why we’ll be here next year,” — Gerald Scholl, Senior Product Manager, B. Braun Group These collaborations are central to the NYSORAs’ events purpose: creating an environment where industry experts gain first-hand understanding of evolving clinical practices, and clinicians experience the latest technologies with the people who develop them. This exchange accelerates innovation and supports both better training and patient care. While the Leuven Anesthesia Summit is a flagship event, NYSORA’s platform for industry-clinician collaboration extends globally, from specialized workshops to large-scale international symposiums. Each event provides a targeted opportunity for companies to engage directly with the medical community and shape the future of their fields. With the 2026 Anesthesia […]
September 10, 2025
